Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals

Mario A. Peña-Hernández, Jon Klein, Amyn A. Malik, Andreas Coppi, View ORCID ProfileChaney Kalinich, Chantal B. F. Vogels, View ORCID ProfileJulio Silva, Yale SARS-CoV-2 Genomic Surveillance Initiative, David R. Peaper, Marie-Louise Landry, Craig Wilen, Nathan D. Grubaugh, View ORCID ProfileWade Schulz, Saad B. Omer, View ORCID ProfileAkiko Iwasaki
doi: https://doi.org/10.1101/2021.12.28.21268460
Mario A. Peña-Hernández
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
2Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Klein
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
3MD/PhD Program, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amyn A. Malik
4Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
5Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Coppi
4Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
6Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chaney Kalinich
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chaney Kalinich
Chantal B. F. Vogels
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Silva
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
3MD/PhD Program, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julio Silva
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
David R. Peaper
8Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Louise Landry
8Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA
9Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT, USA
10Clinical Virology Laboratory, Yale New Haven Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Wilen
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
8Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan D. Grubaugh
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wade Schulz
6Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA
8Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wade Schulz
Saad B. Omer
5Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
9Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT, USA
11Yale School of Nursing, Yale University, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Iwasaki
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
12Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, US
13Howard Hughes Medical Institute, Chevy Chase, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akiko Iwasaki
  • For correspondence: akiko.iwasaki@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The frequency of SARS-CoV-2 breakthrough infections in fully vaccinated individuals increased with the emergence of the Delta variant, particularly with longer time from vaccine completion. However, whether breakthrough infections lead to onward transmission remains unclear. Here, we conducted a study involving 125 patients comprised of 72 vaccinated and 53 unvaccinated individuals, to assess the levels of infectious virus in vaccinated and unvaccinated individuals. Quantitative plaque assays showed no significant differences in the titers of virus between these cohorts. However, the proportion of nasopharyngeal samples with culturable virus was lower in the vaccinated patients relative to unvaccinated patients (21% vs. 40%). Finally, time-to-event analysis with Kaplan-Myer curves revealed that protection from culturable infectious virus waned significantly starting at 5 months after completing a 2-dose regimen of mRNA vaccines. These results have important implications in timing of booster dose to prevent onward transmission from breakthrough cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by research grants from Dr. Akiko Iwasaki.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of Yale University gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • - Correction of text. - Correction of y-axis label in Figure 1c.

Data Availability

All data produced in the present work are contained in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 08, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals
Mario A. Peña-Hernández, Jon Klein, Amyn A. Malik, Andreas Coppi, Chaney Kalinich, Chantal B. F. Vogels, Julio Silva, Yale SARS-CoV-2 Genomic Surveillance Initiative, David R. Peaper, Marie-Louise Landry, Craig Wilen, Nathan D. Grubaugh, Wade Schulz, Saad B. Omer, Akiko Iwasaki
medRxiv 2021.12.28.21268460; doi: https://doi.org/10.1101/2021.12.28.21268460
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals
Mario A. Peña-Hernández, Jon Klein, Amyn A. Malik, Andreas Coppi, Chaney Kalinich, Chantal B. F. Vogels, Julio Silva, Yale SARS-CoV-2 Genomic Surveillance Initiative, David R. Peaper, Marie-Louise Landry, Craig Wilen, Nathan D. Grubaugh, Wade Schulz, Saad B. Omer, Akiko Iwasaki
medRxiv 2021.12.28.21268460; doi: https://doi.org/10.1101/2021.12.28.21268460

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1245)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
  • Epidemiology (10032)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2464)
  • Geriatric Medicine (238)
  • Health Economics (480)
  • Health Informatics (1647)
  • Health Policy (754)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11872)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2290)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1249)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (734)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4843)
  • Radiology and Imaging (843)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (652)
  • Rheumatology (286)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (269)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)